News archive search

Search the Newsreel

Search stored headlines and summaries, then narrow the results by company, country, sector, industry, source or date.

Showing
1–11
Matches
11
Sources here
1
Companies here
2
Search results Stored financial headlines

Active search

11 matching headlines

Ticker or company: IPNMain company stories
Clear
Latest

finance.yahoo.com Market update

IPSEN - Buy-back programme - Art 5 of MAR - Week 32 - 2026

Ipsen Pharma Aggregated presentation by day and by market Weekly report on share repurchases from 04th August to 05th August 2026 Name of the Issuer Identify code of the Issuer Transaction day Identify code of the financial instrument Total daily volume (in number of shares) Daily weighted average purchase price of the shares Market (MIC Code) IPSEN 549300M6SGDPB4Z94P11 …

Main company 🇫🇷 France
Read at finance.yahoo.com
Sharemaestro market context Trend signal active 52 weeks +33.7% IPN stored weekly price path from 22 Aug 2025 to 14 Aug 2026
Just inNext headlines
finance.yahoo.com Market update Main company 🇫🇷 France

IPSEN - Buy-back programme - Art 5 of MAR - Week 31 - 2026

Ipsen Pharma Aggregated presentation by day and by market Weekly report on share repurchases from 27th July to 31st July 2026 Name of the Issuer Identify code of the Issuer Transaction day Identify code of the financial instrument Total daily volume (in number of …

IPN main company
Sharemaestro market context Trend signal active 52 weeks +33.7% IPN stored weekly price path from 22 Aug 2025 to 14 Aug 2026
finance.yahoo.com Deals and strategy Main company 🇫🇷 France

Ipsen SA (IPSEY) (H1 2026) Earnings Call Highlights: Record Sales and Margin Growth Amid ...

This article first appeared on GuruFocus. Release Date: July 30, 2026 For the complete transcript of the earnings call, please refer to the full earnings call transcript. Positive Points Total sales grew 23.5% at constant exchange rates, with a record core operating margin of …

IPN main company
Sharemaestro market context Trend signal active 52 weeks +33.7% IPN stored weekly price path from 22 Aug 2025 to 14 Aug 2026

Search results

Matching headlines

External headlines link to their original source. Market context comes from stored weekly company data, not from an opinion about the article.

finance.yahoo.com Guidance Main company 🇫🇷 France

Ipsen slips despite raising outlook on broad-based drug sales growth

Investing.com -- Shares in French drugmaker Ipsen SA slippedon Thursday even as the company's second-quarter product sales of €1,115 million beat company-compiled consensus of €1,048 million by 6%, or €67 million, helped by strong Somatuline sales amid limited generic competition. Second-quarter product sales grew …

IPN main company
Sharemaestro market context Trend signal active 52 weeks +33.7% IPN stored weekly price path from 22 Aug 2025 to 14 Aug 2026
finance.yahoo.com Earnings Main company 🇫🇷 France

Ipsen delivers excellent H1 2026 results and upgrades its full-year guidance

Ipsen Pharma H1 2026 results with sales growth of 23.5% at CER1, or 20.4% as reported, with the portfolio beyond Somatuline® achieving sales growth of 24.8%1 and core operating income of €845m, growing by 28.8% as reported, with a core operating margin of 38.6% …

IPN main company
Sharemaestro market context Trend signal active 52 weeks +33.7% IPN stored weekly price path from 22 Aug 2025 to 14 Aug 2026
finance.yahoo.com Deals and strategy Main company 🇫🇷 France

Ipsen (ENXTPA:IPN) Stock Looks Stretched On Earnings But Reasonable On Cash Flow

Get insights on thousands of stocks from the global community of over 7 million individual investors at Simply Wall St. Ipsen stock has delivered an 85.4% return over the past 5 years, yet the valuation picture is split, with the Discounted Cash Flow (DCF) …

IPN main company
Sharemaestro market context Trend signal active 52 weeks +33.7% IPN stored weekly price path from 22 Aug 2025 to 14 Aug 2026
finance.yahoo.com Capital return Main company 🇫🇷 France

IPSEN - Buy-back programme - Art 5 of MAR - Week 30 - 2026

Ipsen Pharma Aggregated presentation by day and by market Weekly report on share repurchases from 20th July to 24th July 2026 Name of the Issuer Identify code of the Issuer Transaction day Identify code of the financial instrument Total daily volume (in number of …

IPN main company
Sharemaestro market context Trend signal active 52 weeks +33.7% IPN stored weekly price path from 22 Aug 2025 to 14 Aug 2026
finance.yahoo.com Earnings Main company 🇫🇷 France

Ipsen provides update on Phase III BOLD trial in biliary atresia

Ipsen Pharma PARIS, FRANCE, 24 JULY 2026 - Ipsen (Euronext: IPN; ADR: IPSEY) announced today that the Phase III BOLD trial evaluating Bylvay versus placebo for patients living with biliary atresia (BA) who have already undergone a Kasai hepatoportoenterostomy (HPE) did not meet the …

IPN main company
Sharemaestro market context Trend signal active 52 weeks +33.7% IPN stored weekly price path from 22 Aug 2025 to 14 Aug 2026
finance.yahoo.com Market update Main company 🇫🇷 France

Ipsen - Corrective statement amending the monthly disclosure of the total number of shares and voting rights as of June 30, 2026

Ipsen Pharma CORRECTIVE STATEMENT Corrective statement amending the monthly disclosure of the total number of shares and voting rights as of June 30, 2026, published on July 9, 2026 Paris, July 22, 2026 This corrective statement is issued pursuant to Article L. 233-8 II …

IPN main company
Sharemaestro market context Trend signal active 52 weeks +33.7% IPN stored weekly price path from 22 Aug 2025 to 14 Aug 2026
finance.yahoo.com Deals and strategy Main company 🇫🇷 France

Ipsen completes acquisition of Memo Therapeutics AG, adding first-in-class asset to Ipsen's Rare Disease pipeline

Ipsen Pharma PARIS, FRANCE, 22 JULY 2026 - Ipsen (Euronext: IPN; ADR: IPSEY) announced today it has completed the acquisition of Memo Therapeutics AG, a late-stage biotech company focused on potravitug, an anti-BK polyomavirus monoclonal antibody. About potravitug Potravitug is a first-in-class monoclonal antibody …

IPN main company
Sharemaestro market context Trend signal active 52 weeks +33.7% IPN stored weekly price path from 22 Aug 2025 to 14 Aug 2026
finance.yahoo.com Capital return Main company 🇫🇷 France

IPSEN - Buy-back programme - Art 5 of MAR - Week 29 - 2026

Ipsen Pharma Aggregated presentation by day and by market Weekly report on share repurchases from 13th July to 17th July 2026 Name of the Issuer Identify code of the Issuer Transaction day Identify code of the financial instrument Total daily volume (in number of …

IPN main company
Sharemaestro market context Trend signal active 52 weeks +33.7% IPN stored weekly price path from 22 Aug 2025 to 14 Aug 2026

Find financial news

Search the Newsreel

Use one field or combine several. Results are newest first.

Evidence context